1102. Reconstitution of CMV-specific cell-mediated immunity during letermovir prophylaxis in hematopoietic stem cell recipients

por Abidi, Maheen, Gutman, Jonathan, Weinberg, Adriana
Publicado 2020

Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine

por Zhang, Alexander, Johnson, Tanner, Abbott, Diana, Phupitakphol, Tanit, Gutman, Jonathan A, Pollyea, Daniel A, Koullias, Yiannis
Publicado 2022

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

por Amaya, Maria, Mcmahon, Christine, Aaron Gutman, Jonathan, Schwartz, Marc, Sevens, Brett, Sohalski, Connor, Tobin, Jennifer, Smith, Clayton, T Jordan, Craig, Aaron Pollyea, Daniel
Publicado 2023

Expansion of Human and Murine Hematopoietic Stem and Progenitor Cells Ex Vivo without Genetic Modification Using MYC and Bcl-2 Fusion Proteins

por Bird, Gregory A., Polsky, Avital, Estes, Patricia, Hanlon, Teri, Hamilton, Haley, Morton, John J., Gutman, Jonathan, Jimeno, Antonio, Turner, Brian C., Refaeli, Yosef
Publicado 2014

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia

por Cherry, Evan M., Abbott, Diana, Amaya, Maria, McMahon, Christine, Schwartz, Marc, Rosser, Julie, Sato, Audrey, Schowinsky, Jeffrey, Inguva, Anagha, Minhajuddin, Mohd, Pei, Shanshan, Stevens, Brett, Winters, Amanda, Jordan, Craig T., Smith, Clayton, Gutman, Jonathan A., Pollyea, Daniel A.
Publicado 2021

Progress toward curing HIV infection with hematopoietic cell transplantation

por Petz, Lawrence D, Burnett, John C, Li, Haitang, Li, Shirley, Tonai, Richard, Bakalinskaya, Milena, Shpall, Elizabeth J, Armitage, Sue, Kurtzberg, Joanne, Regan, Donna M, Clark, Pamela, Querol, Sergio, Gutman, Jonathan A, Spellman, Stephen R, Gragert, Loren, Rossi, John J
Publicado 2015

Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents

por Miller, Matthew A, Molina, Kyle C, Gutman, Jonathan A, Scherger, Sias, Lum, Jessica M, Mossad, Sherif B, Burgess, Mary, Cheng, Matthew P, Chuang, Sally T, Jacobs, Samantha E, Melendez, Dante P, Shah, Dimpy P, Zimmer, Andrea, Sohail, M Rizwan, Syed, Sadia, Walker, Randall C, Poeschla, Eric M, Abidi, Maheen Z
Publicado 2020

Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia

por Gutman, Jonathan A., Winters, Amanda, Kent, Andrew, Amaya, Maria, McMahon, Christine, Smith, Clayton, Jordan, Craig T., Stevens, Brett, Minhajuddin, Mohammad, Pei, Shanshan, Schowinsky, Jeffrey, Tobin, Jennifer, O’Brien, Kelly, Falco, Angela, Taylor, Elizabeth, Brecl, Constance, Zhou, Katie, Ho, Phuong, Sohalski, Connor, Dell-Martin, Jessica, Ondracek, Olivia, Abbott, Diana, Pollyea, Daniel A.
Publicado 2023

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades

por Cooper, Jason P., Storer, Barry E., Granot, Noa, Gyurkocza, Boglarka, Sorror, Mohamed L., Chauncey, Thomas R., Shizuru, Judith, Franke, Georg-Nikolaus, Maris, Michael B., Boyer, Michael, Bruno, Benedetto, Sahebi, Firoozeh, Langston, Amelia A., Hari, Parameswaran, Agura, Edward D., Petersen, Søren Lykke, Maziarz, Richard T., Bethge, Wolfgang, Asch, Julie, Gutman, Jonathan A., Olesen, Gitte, Yeager, Andrew M., Hübel, Kai, Hogan, William J., Maloney, David G., Mielcarek, Marco, Martin, Paul J., Flowers, Mary E. D., Georges, George E., Woolfrey, Ann E., Deeg, H. Joachim, Scott, Bart L., McDonald, George B., Storb, Rainer, Sandmaier, Brenda M.
Publicado 2020